A Non-Interventional, Post-Marketing Surveillance Phase IV Study to Asses the Efficacy and Safety of Telmisartan, With the Special Attention on the Influence of Telmisartan on Selected Metabolic Parameters of Patients.

Trial Profile

A Non-Interventional, Post-Marketing Surveillance Phase IV Study to Asses the Efficacy and Safety of Telmisartan, With the Special Attention on the Influence of Telmisartan on Selected Metabolic Parameters of Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Feb 2010

At a glance

  • Drugs Telmisartan (Primary)
  • Indications Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms METABOLIC
  • Sponsors Bayer
  • Most Recent Events

    • 26 Jan 2010 Actual number of patients (5448) added as reported by ClinicalTrials.gov record.
    • 26 Jan 2010 Actual number of patients (5448) added as reported by ClinicalTrials.gov record.
    • 26 Jan 2010 Actual end date (1 Nov 2009) added as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top